SCHEMBL1376747

SCHEMBL1376747

COc1cc(-c2cc(C(Nc3ccc(-c4nc[nH]n4)cc3)S(=O)(=O)c3ccc(C)cc3)c[nH]2)cc(OC)c1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.36
AR P10275 1/20 0.36
FYN P06241 2/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 4/20 0.33
LMNA P02545 2/20 0.33
GHSR Q92847 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380043 0.80 POLB (0.38) PGRARHTTKMT2AGHSR
SCHEMBL1377866 0.79 MAPT (0.46) KMT2AALDH1A1KDM4EMAPTHPGD
SCHEMBL7121261 0.62 TUBB4A (0.44) HTTKMT2AALDH1A1LMNAKDM4E
SCHEMBL1230218 0.62 METAP2 (0.44) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL6865616 0.58 ALDH1A1 (0.44) ARALDH1A1MAPT
SCHEMBL7121715 0.58 TUBB4A (0.44) HTTKMT2AALDH1A1LMNAKDM4E
SCHEMBL7121265 0.57 CA1 (0.45) PGRARHTTKMT2AALDH1A1
SCHEMBL28864522 0.57 LMNA (0.68) HTTKMT2AALDH1A1LMNAMAPT
SCHEMBL12180354 0.56 CA1 (0.40) PGRARHTTKMT2AALDH1A1
SCHEMBL12844430 0.56 ACHE (0.60) HTTKMT2AALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4716996-B2 2011-07-06 JP claimed
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP claimed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US claimed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US claimed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP claimed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 PGR 2395/4885AR 1259/4885FYN 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.